Clinical Trials Logo

Muscle Weakness clinical trials

View clinical trials related to Muscle Weakness.

Filter by:

NCT ID: NCT06120738 Recruiting - Adolescents Clinical Trials

The Effect Of Smartphone Addiction On Trunk Muscles Performance In Adolescents

Start date: April 1, 2023
Phase:
Study type: Observational

Statement of the problem: Does overuse of the smartphones affect trunk muscles performance in normal adolescents it will be assumed that There will be no affection of smartphone addiction on trunk muscles performance in normal adolescents

NCT ID: NCT06081504 Recruiting - Burns Clinical Trials

Wii Fit Exercises Versus Pilates Exercises in Adult Patients With Lower Extremity Burn

Start date: October 10, 2023
Phase: N/A
Study type: Interventional

The aim of the study is to compare the effect of Wii fit exercises and Pilates exercises on muscle strength and postural balance, and functional performance in adult patients with lower extremity burn.

NCT ID: NCT06064695 Recruiting - Clinical trials for Generalized Myasthenia Gravis

Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Myasthenia Gravis

Start date: July 12, 2023
Phase: N/A
Study type: Interventional

During this pilot study, the investigators will examine the effects of whole-body electrical muscle stimulation exercise (WB-EMS Exercise) on neuromuscular junction (NMJ) transmission and fatigability in adults with Generalized Myasthenia Gravis (gMG). The investigators will also test whether a relationship exists between NMJ transmission dysfunction and fatigability in gMG, which has long been presumed but never directly assessed. Participants will undergo clinical and electrophysiologic testing before and after the WB-EMS Exercise intervention. The WB-EMS Exercise intervention will be delivered 2 times per week for 4 weeks. The hypotheses are (a) that the WB-EMS exercise will improve fatigability and NMJ transmission, and (b) that NMJ transmission dysfunction is related to fatigability.

NCT ID: NCT06055959 Recruiting - Clinical trials for Generalized Myasthenia Gravis

A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis

ziMyG
Start date: June 11, 2024
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to assess the pharmacokinetics, pharmacodynamics, safety, tolerability, immunogenicity and activity of zilucoplan (ZLP) in pediatric study participants with generalized myasthenia gravis (gMG).

NCT ID: NCT06020703 Recruiting - COVID-19 Clinical Trials

A Study of Healthy Microbiome, Healthy Mind

Start date: February 26, 2024
Phase: N/A
Study type: Interventional

Researchers are doing this study to find out if a high fermented food diet is tolerable, and if it will help improve quality of life after surviving a critical illness, including severe COVID-19, by promoting gut health recovery and decreasing gut inflammation.

NCT ID: NCT06006832 Recruiting - Myasthenia Gravis Clinical Trials

A Prospective Cohort Study of Myasthenia Gravis in China

Start date: August 20, 2023
Phase:
Study type: Observational

The goal of this prospective cohort study is to investigate long-term therapeutic strategies for myasthenia gravis (MG) and identify potential biomarkers. The main questions it aims to answer are: 1. Whether low-dose oral steroids may lead to a reduction in the recurrence rate among patients with MG. 2. To identify potential biomarkers that can predict disease progression and prognosis. This study recruits well-controlled patients with MG. Based on patient preferences and considerations such as coexisting conditions (e.g., uncontrolled hypertension, diabetes, severe osteoporosis, obesity), the participants will be non-randomly divided into two groups: a maintenance steroid therapy group and a withdrawal group (withdraw all immunosuppresants). Subsequently, these groups of patients will undergo long-term follow-up assessments.

NCT ID: NCT06002945 Recruiting - Myasthenia Gravis Clinical Trials

Exploring Outcomes and Characteristics of Myasthenia Gravis 2

EXPLORE-MG2
Start date: January 12, 2021
Phase:
Study type: Observational [Patient Registry]

The goal of this prospective observational study is to create a network repository of clinical data and biological samples to help researchers learn more about myasthenia gravis.

NCT ID: NCT05992025 Recruiting - Myasthenia Gravis Clinical Trials

Digital Phenotyping and Lifestyle Intervention in Patients With Myasthenia Gravis

DIG-MG
Start date: July 10, 2023
Phase: N/A
Study type: Interventional

Myasthenia Gravis (MG) is a chronic autoimmune neurological disorder where an antibody attack of muscle receptors causes fatigable skeletal muscle weakness. In addition to fatigue, several MG patients experience general fatigue. Small supervised studies during 12 weeks of physical exercise interventions have indicated safety and beneficial neuromuscular outcomes in MG patients. Longer and unsupervised studies are required to obtain guidelines for physical activity in MG patients. Further, the development of smart rings enables remote digital supervision of physical activity, sleep, and biological parameters such as heart frequency, number of steps, and temperature. These parameters could add to the lack of biomarkers in MG. The project design is a randomized controlled trial with a lifestyle intervention to improve fatigue in the autoimmune neuromuscular disease Myasthenia Gravis (MG). The intervention includes digital group counseling regarding physical activity, sleep, general health, and digital follow-up with a "smart ring" (OURA).

NCT ID: NCT05967611 Recruiting - Weakness, Muscle Clinical Trials

Hip Abductor Function During Trendelenburg Test

Start date: July 25, 2023
Phase:
Study type: Observational

This study will use electromyography and dynamometry to evaluate gluteal muscle activation during the Trendelenburg hip abduction test in different hip positions.

NCT ID: NCT05956964 Recruiting - Muscle Weakness Clinical Trials

NM Balance Regulation With ULLS and Loss of Sleep

Start date: August 10, 2023
Phase: N/A
Study type: Interventional

The goal of this trial is to learn about how restricted sleep and not bearing weight on the leg affects muscle strength and posture control. Participants will walk exclusively on one leg, sleep at differing intervals, and complete posture tests, muscle strength tests, and muscle imaging. Researchers will compare adequate sleep and restricted sleep to see if muscle strength and posture are affected.